In the months before his wedding, Queens resident Roberto Pineda Sanchez noticed persistent rectal bleeding, a dangerous symptom he almost ignored.
Q4 2025 earnings call: 15% revenue growth, $3.9M sales, CapsoCam Colon Gen 2/AI 510(k) timing, trials & funding—read now.
CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results for the fourth ...
CapsoVision (NASDAQ:CV) executives used a fireside chat hosted by Roth Senior Research Analyst Kyle Bauser to outline the ...
Discover the groundbreaking capsule endoscopy—a tiny, wireless camera encased in a transparent pill-sized capsule. This ...
(the “Company”) (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced the closing of a $14 million private ...
Abstract: Gastric cancer remains a global health challenge with high mortality rates, underscoring the urgent need for advanced diagnostic tools. While conventional gastroscopy encounters patient ...
Ingestible smart capsules deliver medication directly to specific gut locations using microscopic needles and targeted drug release systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results